
Gene knockout cell lines are generated using CRISPR-Cas9 based technology to precisely disrupt target genes, enabling functional genomics research, disease modeling, and target validation.
ZNF639 (zinc finger protein 639) encodes a Kruppel-like zinc finger protein that functions as a sequence-specific DNA-binding transcriptional regulator. It contributes to regulation of gene expression by interacting with target DNA sequences and modulating transcriptional activity.
JIMT-1 is a human breast cancer cell line established from the pleural effusion of a 62-year-old female patient with grade 3 invasive ductal breast carcinoma (T2N1M0) after postoperative radiation therapy. The cells carry amplification of the HER2 oncogene and have been reported to be insensitive to HER2-targeted therapies, including trastuzumab. JIMT-1 is widely used as a model for studying HER2-positive breast cancer biology, mechanisms of therapeutic resistance, and evaluation of novel anti-HER2 treatments.
Comprehensive quality control includes STR authentication, sterility testing (bacteria and fungi), and mycoplasma screening to ensure purity and performance. Genotype is confirmed by two rounds of PCR and Sanger sequencing, and complete validation reports are provided for make-to-order products.

Cas9 cell lines in our cell bank can stably express Cas9 protein. Each Cas9 Stable Cell Line is easy to use and enables gene knockout simply by transfecting gRNA, while transfection of gRNA and donor DNA results in gene knock-in or point mutations
These Cas9 stable cell lines have been used to construct the KO cell lines for various genes, gene KO efficiency 5-10 times improved.
Selected cells, low passages, good cell condition, high activity, applicable for all kinds of gene-editing experiments.

Targeted knockout region: EExon 7
Reference Transcript: NM_001375806
Frameshift Mutation Strategy
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use





Simply fill out the form below to leave your inquiry
— we will respond within 24 Hours.
* Name
* Institution
* Products & Services of Interest
If email is not available, how else can we reach you?
How did you hear about us?